Overview

Immediate Postpartum Nexplanon Placement in Opioid Dependent Women

Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The investigators have designed a single site, Phase IV open label, prospective observational clinical trial to compare the effect of immediate postpartum Nexplanon placement (IPP) versus standard postpartum contraceptive care (control) on consistent contraceptive use and rapid repeat pregnancy at 12 months postpartum in 200 opioid dependent (OD) women.
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Contraceptive Agents
Desogestrel
Etonogestrel